Retevmo 120 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FG4CT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,879
Award facts
- Contract value 100% obligated
- $16,879.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On February 4, 2026, the Defense Logistics Agency awarded a delivery order valued at $16,879.41 to AmerisourceBergen Drug Corp for the supply of Retevmo 120 mg tablets (60-count units). The contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 26, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor providing critical medical supply support to federal military and veteran healthcare systems.
This delivery order falls under the DLA's comprehensive pharmaceutical supply chain framework, which leverages prime vendor contracts to efficiently distribute brand-name and generic medications, vaccines, and specialized medical supplies to support military treatment facilities and healthcare programs globally. The supply of Retevmo, an oncology medication, aligns with the broader portfolio of therapeutic products AmerisourceBergen delivers through its federal contract vehicles, demonstrating the contractor's established capability to meet government healthcare procurement requirements on an accelerated timeline.
Quick answers
Who was awarded contract SPE2DR26FG4CT?
SPE2DR26FG4CT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FG4CT worth?
The government has obligated $16,879 on SPE2DR26FG4CT.
Is contract SPE2DR26FG4CT an order under another contract?
Yes. SPE2DR26FG4CT is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG4CT competed?
The extent of competition for SPE2DR26FG4CT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award